CCCC
C4 Therapeutics·NASDAQ
--
--(--)
--
--(--)
CCCC fundamentals
C4 Therapeutics (CCCC) released its earnings on Aug 7, 2025: revenue was 6.46M (YoY -46.17%), missed estimates; EPS was -0.37 (YoY -42.31%), beat estimates.
Revenue / YoY
6.46M
-46.17%
EPS / YoY
-0.37
-42.31%
Report date
Aug 7, 2025
Earnings Call
7:00 AM on Aug 7, 2025
Meeting link.EPS
Actual | -0.41 | -0.26 | -0.35 | -0.49 | -0.37 | -0.37 | |||||||||||||
Forecast | -0.3649 | -0.3644 | -0.379 | -0.4931 | -0.442 | -0.384 | |||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -12.36% | +28.65% | +7.65% | +0.63% | +16.29% | +3.65% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.04M | 12.01M | 15.40M | 5.18M | 7.20M | 6.46M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 11.99M | 4.78M | 5.90M | 5.09M | 4.45M | 6.55M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -74.66% | +151.00% | +160.97% | +1.66% | +61.80% | -1.33% |
Earnings Call
You can ask Aime
What is C4 Therapeutics's gross profit margin?What is C4 Therapeutics's latest dividend and current dividend yield?What does C4 Therapeutics do and what are its main business segments?What were the key takeaways from C4 Therapeutics’s earnings call?What is the market's earnings forecast for C4 Therapeutics next quarter?What is the revenue and EPS growth rate for C4 Therapeutics year over year?What guidance did C4 Therapeutics's management provide for the next earnings period?Did C4 Therapeutics beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
